European Society of Cardiology (ESC)

This page includes news from the European Society of Cardiology (ESC). The ESC represents more than 95,000 men and women in the field of cardiology from Europe, the Mediterranean basin. It is the European umbrella cardiology organization, which includes the European Association of Percutaneous Cardiovascular Interventions (EAPCI), which hosts the large EuroPCR meeting; the European Heart Rhythm Society (EHRA); European Association of Cardiovascular Imaging (EACVI); European Association of Preventive Cardiology (EAPC); and the Association for Acute Cardiovascular Care (ACVC).

Predicting sudden cardiac death after a heart attack may be impossible—for now
Researchers tried to crack the code, but they fell short time and time again. AI may offer potential as one way to finally find an answer, they added.
SAVR associated with several long-term benefits for patients with asymptomatic severe AS
The current evidence suggests early surgery is a better treatment option for asymptomatic severe AS than conservative care, researchers explained.
JACC editor excited by progress during a 'very important moment' for cardiology
Harlan Krumholz, MD, editor-in-chief of the Journal of the American College of Cardiology, explains some of the key technology and treatment trends he has his eyes on.
Treating AFib with another ablation after PVI provides little value
Care teams regularly targeting AFib symptoms with LVA ablation in addition to PVI may want to reconsider.
Pausing oral anticoagulation during TAVR reduces bleeding risk
The findings, based on data from more than 800 TAVR patients, suggest that skipping OAC medications for a small amount of time could make a big impact.

Shear wave imaging ‘extremely promising’ for assessment of myocardial stiffness in heart transplant recipients

The noninvasive technique shows potential where cardiac magnetic resonance imaging falls short.

August 31, 2020

Empagliflozin reduces risk of cardiovascular death, hospitalization among heart failure patients

The EMPEROR-Reduced trial included data from more than 3,700 adult patients with HF and a left ventricular ejection fraction of 40% or less.

August 31, 2020

How to predict a CVD patient’s risk of total, colorectal and lung cancer

The analysis was presented at ESC Congress 2020 and published in JACC: CardioOncology.

August 28, 2020

Burnout in cardiology: Most pediatric heart nurses feel exhausted, with 30% eyeing a career change

Nurses are unhappy with their working conditions, which leads to stress and exhaustion.

August 28, 2020

More cardiology conferences canceled over COVID-19 concerns

Healthcare conferences all over the world have been delayed or canceled due to the COVID-19 pandemic, and two more significant cancellations have been announced that impact cardiology professionals.

March 26, 2020

Tafamidis shows promise for treating cardiac amyloidosis

Research presented this week at the European Society of Cardiology Congress in Munich suggests a new treatment may be emerging for transthyretin amyloid cardiomyopathy—a condition previously thought to be rare and untreatable.

August 28, 2018

Pope Francis addresses attendees at the European Society of Cardiology Congress in Rome

Pope Francis spoke at the European Society of Cardiology Congress in Rome, Italy and encouraged cardiologists to treat the weak and poor, the Catholic News Agency reports.

September 2, 2016

Around the web

Health Imaging

Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Health Imaging

New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

European Society of Cardiology (ESC)

Predicting sudden cardiac death after a heart attack may be impossible—for now

SAVR associated with several long-term benefits for patients with asymptomatic severe AS

JACC editor excited by progress during a 'very important moment' for cardiology

Treating AFib with another ablation after PVI provides little value

Pausing oral anticoagulation during TAVR reduces bleeding risk

Around the web